
    
      In this protocol, we plan to use the uniqueness of the Cyberknife system to deliver an
      adjuvant single fraction radiation dose. We anticipate that this radiation deliver system
      will reduce toxicity and improve cosmesis. Extrapolating from an intra-operative body of
      work, this Phase I study will attempt to achieve a non-invasive low toxicity profile and
      maintain good to excellent cosmesis. In this effort, the Cyberknife system will be used to
      achieve high conformality and dose gradient.
    
  